BiotechTube
Home/Aspira Women's Health/Nicole Sandford
NS

Nicole Sandford

President and CEO

Aspira Women's Health

Therapeutic Areas

Gynecologic OncologyOvarian Cancer

Aspira Women's Health Pipeline

DrugIndicationPhase
OvaWatchLongitudinal risk monitoring of indeterminate/benign adnexal massesCommercial
Ova1PlusPre-surgical risk assessment of adnexal masses (reflex protocol)Commercial
Ova1Pre-surgical risk assessment of adnexal massesCommercial
OveraPre-surgical risk assessment (reflex test)Commercial
Next-Gen Biomarker DiscoveryImproved ovarian cancer detectionResearch

Leadership Team at Aspira Women's Health

RG
Robert G. Bullock
Key Scientific Leader/R&D (inferred from publications)
KE
Kevin Elias
Clinical Advisor (Cleveland Clinic, referenced in research)
View full Aspira Women's Health profile